A E Voskuyl

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study
    Maria J Overbeek
    Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
    Respir Res 9:68. 2008
  2. ncbi Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease
    Maria J Overbeek
    Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Arthritis Res Ther 13:R61. 2011
  3. ncbi Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus
    Irene E M Bultink
    Department of Rheumatology, VU University Medical Center, Postbox 7057, Amsterdam 1007 MB, The Netherlands
    Arthritis Res Ther 8:R183. 2006
  4. ncbi Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
    Vokko P van Halm
    Department of Rheumatology, VU University Medical Center, Boelelaan 1117, Amsterdam, 1085 HV, The Netherlands
    Arthritis Res Ther 8:R151. 2006
  5. ncbi Remission and radiographic progression in rheumatoid arthritis
    A E Voskuyl
    VU University Medical Center, Amsterdam, The Netherlands
    Clin Exp Rheumatol 24:S-37-40. 2006
  6. ncbi Diagnostic strategy for the assessment of rheumatoid vasculitis
    A E Voskuyl
    Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
    Ann Rheum Dis 62:407-13. 2003
  7. ncbi The heart and cardiovascular manifestations in rheumatoid arthritis
    A E Voskuyl
    Department of Rheumatology, 4 A 42, VU University Medical Center, POB 9057, 1007 MB Amsterdam, The Netherlands
    Rheumatology (Oxford) 45:iv4-7. 2006
  8. ncbi Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
    M J L Peters
    Department of Rheumatology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 66:958-61. 2007
  9. ncbi Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial
    L H D van Tuyl
    Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
    Ann Rheum Dis 67:1574-7. 2008
  10. ncbi Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
    A Jamnitski
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Ann Rheum Dis 69:1929-33. 2010

Detail Information

Publications56

  1. ncbi Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study
    Maria J Overbeek
    Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
    Respir Res 9:68. 2008
    ..The use of the partitioned diffusion to detect PAH in SSc is not well established yet. This study evaluates whether Dm and Vc could be candidates for further study of the use for screening for PAH in SSc...
  2. ncbi Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease
    Maria J Overbeek
    Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Arthritis Res Ther 13:R61. 2011
    ..Immunoreactivity patterns of phosphorylated PDGFR-β (pPDGFR-β) and the ligand PDGF-B were evaluated to provide more insight into the patterns of PDGFR-b activation...
  3. ncbi Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus
    Irene E M Bultink
    Department of Rheumatology, VU University Medical Center, Postbox 7057, Amsterdam 1007 MB, The Netherlands
    Arthritis Res Ther 8:R183. 2006
    ..In conclusion, SLE patients frequently suffer from infections, but deficiency of functional MBL does not confer additional risk...
  4. ncbi Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
    Vokko P van Halm
    Department of Rheumatology, VU University Medical Center, Boelelaan 1117, Amsterdam, 1085 HV, The Netherlands
    Arthritis Res Ther 8:R151. 2006
    ..We hypothesize that DMARD use, in particular MTX use, results in powerful suppression of inflammation, thereby reducing the development of atherosclerosis and subsequently clinically overt CVD...
  5. ncbi Remission and radiographic progression in rheumatoid arthritis
    A E Voskuyl
    VU University Medical Center, Amsterdam, The Netherlands
    Clin Exp Rheumatol 24:S-37-40. 2006
    ..Until these techniques are validated and assessed for predictive value, we would advocate that radiographic progression be added to existing criteria for clinical remission, in order to define remission in RA more comprehensively...
  6. ncbi Diagnostic strategy for the assessment of rheumatoid vasculitis
    A E Voskuyl
    Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
    Ann Rheum Dis 62:407-13. 2003
    ....
  7. ncbi The heart and cardiovascular manifestations in rheumatoid arthritis
    A E Voskuyl
    Department of Rheumatology, 4 A 42, VU University Medical Center, POB 9057, 1007 MB Amsterdam, The Netherlands
    Rheumatology (Oxford) 45:iv4-7. 2006
    ..This overview discusses the epidemiological aspects of these cardiovascular diseases and their relevance for diagnosis and treatment of RA...
  8. ncbi Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
    M J L Peters
    Department of Rheumatology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 66:958-61. 2007
    ..To evaluate the effects of infliximab and corticosteroid treatment on the lipid profile in patients with active rheumatoid arthritis (RA)...
  9. ncbi Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial
    L H D van Tuyl
    Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
    Ann Rheum Dis 67:1574-7. 2008
    ..To investigate the efficacy and feasibility of an intensive combination treatment in early rheumatoid arthritis (RA) combined with monitoring both disease activity and cartilage degradation...
  10. ncbi Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
    A Jamnitski
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Ann Rheum Dis 69:1929-33. 2010
    ..Available evidence is derived from short-term studies, and it is not clear whether TNFα inhibitors have a similar effect on the lipid profile in responders and non-responders to the treatment...
  11. ncbi Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis
    L H D van Tuyl
    Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
    Rheumatology (Oxford) 47:1571-6. 2008
    ..The present qualitative study was carried out to further explore the reservation of Dutch rheumatologists towards prescribing COBRA therapy and include patients' view on (components of) COBRA therapy...
  12. ncbi The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study
    H G Raterman
    VU University Medical Centre, Departments of Internal Medicine and Rheumatology, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 69:39-42. 2010
    ..This study compared first, MetS (features) and second, the Framingham 10-year CVD risk in RA patients with hypothyroidism compared with euthyroid RA patients...
  13. ncbi Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients
    T C T M van der Pouw Kraan
    Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands
    Genes Immun 9:16-22. 2008
    ..We conclude that activation of a host-pathogen response defines a subgroup of RA patients characterized by increased autoreactivity against citrullinated proteins...
  14. ncbi Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis
    V P van Halm
    Departments of Internal Medicine and Rheumatology, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 66:184-8. 2007
    ..It was recently shown that active early rheumatoid arthritis is associated with dyslipidaemia, which may partially explain the enhanced cardiovascular risk. However, it is unknown when this dyslipidaemia starts...
  15. ncbi Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients
    A Jamnitski
    Jan van Breemen Research Institute Reade, Amsterdam, The Netherlands
    Ann Rheum Dis 71:88-91. 2012
    ..To investigate the relationship between serum etanercept levels and clinical response...
  16. ncbi Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
    M Vis
    Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
    Ann Rheum Dis 65:1495-9. 2006
    ....
  17. ncbi Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers
    C L Bos
    Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    Genes Immun 10:210-8. 2009
    ..In conclusion, patients with SSc can be classified on the basis of differential expression of immune defense genes. Differences in the activity of the type I IFN response program stratify patients into two clinically relevant subgroups...
  18. ncbi Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study
    A M van Sijl
    Department of Rheumatology, Jan van Breemen Research Institute Reade, Amsterdam, The Netherlands
    Ann Rheum Dis 71:341-4. 2012
    ..Renal dysfunction is associated with CV morbidity and mortality in the general population, but data on this association in RA are lacking...
  19. ncbi Increased cellularity and expression of adhesion molecules in muscle biopsy specimens from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology
    P C Verschueren
    Leiden University Medical Centre, The Netherlands
    Ann Rheum Dis 59:598-606. 2000
    ..This study aimed at determining the immunohistological features in patients with clinical suspicion of rheumatoid vasculitis, but without a transmural infiltrate or fibrinoid necrosis of the vessel wall on routine histology...
  20. ncbi Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients?
    M Levitus
    Department of Clinical Chemistry, VU University Medical Center, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
    Clin Rheumatol 28:469-74. 2009
    ..7%) and the DAS28 (10.6%). These results suggest that it may be useful to determine the ESR by the Alifax Test-1TH, with a DAS28 misclassification in less than 11% of the patients...
  21. ncbi Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
    M C Lodder
    Department of Rheumatology, Room 4A42, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 63:1576-80. 2004
    ..To examine variables associated with bone mineral density (BMD) in patients with rheumatoid arthritis (RA)...
  22. ncbi Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk
    H G Raterman
    Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
    Ann Rheum Dis 67:229-32. 2008
    ..Our objective was to determine first, the prevalence of hypothyroid disorders in RA patients, and second, the risk of CVD in RA patients with hypothyroid abnormalities...
  23. ncbi Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
    M J Overbeek
    Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
    Eur Respir J 34:371-9. 2009
    ..This might explain its different clinical behaviour from IPAH. Small vessel intimal fibrosis may provide clues to elucidation of differences in pathogenetic mechanisms between the groups...
  24. ncbi Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis
    H A Martens
    Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands
    Lupus 21:959-68. 2012
    ..In addition, we investigated whether these polymorphisms in SLE are associated with serum levels of soluble RAGE (sRAGE), renal involvement (lupus nephritis (LN)) and its outcome...
  25. ncbi Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
    V P van Halm
    Department of Rheumatology, VU University Medical Center, Amsterdam 1007 MB, The Netherlands
    Ann Rheum Dis 68:1395-400. 2009
    ..A study was undertaken to investigate the associations between RA and type 2 diabetes (DM2), a well-established cardiovascular risk factor, on the one hand, and cardiovascular disease (CVD) on the other...
  26. ncbi Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis
    M A Kropholler
    Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
    Eur J Nucl Med Mol Imaging 36:624-31. 2009
    ..This study evaluated methods for the quantification of (R)-[(11)C]PK11195 binding in the knee joints of RA patients...
  27. ncbi Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
    G J Wolbink
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Ann Rheum Dis 64:704-7. 2005
    ..To investigate the relationship between serum trough infliximab levels and clinical response to infliximab treatment in patients with rheumatoid arthritis (RA)...
  28. ncbi Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis
    C J van der Laken
    Department of Rheumatology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 66:253-6. 2007
    ..One of the postulated hypotheses of not responding is the fast clearance of infliximab due to the development of infliximab-anti-infliximab complexes...
  29. ncbi Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus
    I E M Bultink
    Department of Rheumatology, VU University Medical Center, Slotervaart Hospital and Jan van Breemen Institute, Amsterdam, The Netherlands
    Clin Exp Rheumatol 26:32-8. 2008
    ..To examine the prevalence of the metabolic syndrome and the relationship between metabolic syndrome score (MetS score) and disease characteristics and cardiovascular events (CVEs) in women with SLE...
  30. ncbi Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus
    I E M Bultink
    Department of Rheumatology, VU University Medical Centre, Postbus 7057, 1007 MB, Amsterdam, The Netherlands
    Ann Rheum Dis 64:1362-5. 2005
    ..Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide inhibitor and a new independent risk factor for endothelial dysfunction and cardiovascular disease...
  31. ncbi Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis
    H M A Hofstee
    Department of Internal Medicine, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Ann Rheum Dis 68:191-5. 2009
    ....
  32. ncbi Diagnostic strategies for the histological examination of muscle biopsy specimens for the assessment of vasculitis in rheumatoid arthritis
    A H Zwinderman
    Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands
    Stat Med 19:3433-47. 2000
    ..FN appeared to cluster in the RV biopsies, and a first-order Markov model satisfactorily described the (auto)correlation between adjacent tissue sections in RV biopsies...
  33. ncbi Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis
    A van Tellingen
    Department of Nephrology, VU University Medical Centre, Amsterdam, The Netherlands
    Neth J Med 70:199-207. 2012
    ....
  34. ncbi Influence of HLA polymorphism on persistent remission in rheumatoid arthritis
    E T H Molenaar
    Department of Rheumatology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Ann Rheum Dis 61:351-3. 2002
    ..Persistent remission of RA was not associated with any particular HLA subtypes, indicating that HLA typing is not useful for predicting persistent clinical remission...
  35. ncbi The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
    B de Laat
    Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands
    J Thromb Haemost 7:1767-73. 2009
    ..Anti-beta2-glycoprotein I (beta 2GPI) antibodies play a central role in the disease process of APS...
  36. ncbi Symmetrical, painful ulceration of the lower limbs in a vascular surgery ward: a diagnostic challenge. Pyoderma gangrenosum associated with IgG-kappa paraproteinaemia
    S Simsek
    Department of Endocrinology Diabetes Centre, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Neth J Med 62:168-71. 2004
    ....
  37. ncbi [Persistent fever in a patient with Salmonella typhimurium gonarthritis]
    A Becker
    afd Inwendige Geneeskunde, VU Medisch Centrum, De Boelelaan 1117, 1081 HV Amsterdam
    Ned Tijdschr Geneeskd 149:33-6. 2005
    ..In patients with impaired cell-mediated immunity, an extra-intestinal manifestation of Salmonella should be taken into consideration particularly if there appears to be no clinical focus. This may be detected by FDG-PET...
  38. ncbi 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis
    E H Elzinga
    Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
    Mol Imaging Biol 9:357-60. 2007
    ..This study compares FDG uptake in joints of RA and OA patients and FDG-uptake with clinical signs of inflammation...
  39. ncbi Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein
    E T Molenaar
    Vrije Universiteit Medical Center, Amsterdam, The Netherlands
    Arthritis Rheum 44:997-1002. 2001
    ..CONCLUSION: Part of the activation of complement in RA is mediated by CRP and is correlated with disease activity. We suggest that this activation is involved in the pathogenesis of RA...
  40. ncbi Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis
    M Boers
    Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Ann Rheum Dis 62:842-5. 2003
    ..CONCLUSION: In established, but especially in early RA, disease activity is accompanied by atherogenic lipid levels. This dyslipidaemia can be rapidly reversed by aggressive antirheumatic treatment including glucocorticoids...
  41. ncbi Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
    T C T M van der Pouw Kraan
    Department of Molecular and Cellular Biology and Immunology, VU Medical Centre, J295, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Ann Rheum Dis 66:1008-14. 2007
    ..Rheumatoid arthritis (RA) is a heterogeneous disease with unknown cause...
  42. ncbi Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
    M J Overbeek
    Dept of Pulmonary Diseases, VU University Medical Centre, Vrije University, Amsterdam, The Netherlands
    Eur Respir J 31:1160-6. 2008
    ..Right ventricular contractility is lower in systemic sclerosis-associated pulmonary arterial hypertension than in idiopathic pulmonary arterial hypertension...
  43. ncbi Axonal neuropathy with prolonged sulphasalazine use
    M Liedorp
    Department of Neurology and the Department of Rheumatology, V U University Medical Centre, Amsterdam, The Netherlands
    Clin Exp Rheumatol 26:671-2. 2008
    ..Most reported patients developed symptoms several weeks after onset of treatment. We describe a patient with an axonal polyneuropathy that occurred after two years of treatment with sulphasalazine...
  44. ncbi Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis
    K S Steen
    Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
    J Clin Rheumatol 13:92-3. 2007
    ....
  45. ncbi Long-term outcome in polymyositis and dermatomyositis
    I M Bronner
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Ann Rheum Dis 65:1456-61. 2006
    ..In the long term, myositis has a major effect on perceived disability and quality of life, despite the regained muscle strength...
  46. ncbi Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis
    A A Schouffoer
    Leiden University Medical Center, Leiden, The Netherlands
    Arthritis Care Res (Hoboken) 63:909-17. 2011
    ..To compare the effectiveness of a multidisciplinary team care program with usual outpatient care in patients with systemic sclerosis (SSc; scleroderma)...
  47. ncbi Pregnancy, chimerism and lupus nephritis: a multi-centre study
    I C L Kremer Hovinga
    Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
    Lupus 17:541-7. 2008
    ..Our data support the theory that only certain subsets of chimeric cells persist into the maternal circulation after pregnancy...
  48. ncbi Increased prevalence of antithyroid antibodies in rheumatoid arthritis (RA) patients with a low prevalence of hormonal alterations
    H G Raterman
    Autoimmunity 41:337. 2008
  49. ncbi Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis
    V P van Halm
    Department of Rheumatology, VU University Medical Centre, Amsterdam 1007 MB, Netherlands
    Ann Rheum Dis 65:590-4. 2006
    ..These findings could be the result of an altered immune response to HSP60 in rheumatoid arthritis...
  50. ncbi Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice
    N Neven
    Ann Rheum Dis 64:645-6. 2005
  51. ncbi Bone mineral density in patients with rheumatoid arthritis treated with infliximab
    M Vis
    Ann Rheum Dis 64:336-7. 2005
  52. ncbi [Rheumatic diseases as risk factors for cardiovascular disease]
    M T Nurmohamed
    VU Medisch Centrum, afd. Reumatologie, 4A42, Postbus 7057, 1007 MB Amsterdam
    Ned Tijdschr Geneeskd 150:1921-4. 2006
    ..In addition to SLE, RA and AS should be acknowledged as new risk factors for cardiovascular disease...
  53. ncbi Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
    A Familian
    Department of Immunopathology, Sanquin Research at the CLB, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands
    Ann Rheum Dis 64:1003-8. 2005
    ..Tumour necrosis factor (TNF) blocking agents decrease C reactive protein (CRP) levels in rheumatoid arthritis (RA). It has been shown that CRP may contribute to complement activation in RA...
  54. ncbi [Diagnosis of pulmonary hypertension: experiences with 187 patients referred to the VU Medical Center]
    R J Roeleveld
    afd. Longziekten, VU Medisch Centrum, Postbus 7057, 1007 MB Amsterdam
    Ned Tijdschr Geneeskd 148:82-8. 2004
    ..The application of a multidisciplinary diagnostic protocol together with a contribution of specialists with specific expertise can help to adjust the initial diagnosis and sometimes even reject it...
  55. ncbi Polymyositis: an overdiagnosed entity
    M F G van der Meulen
    Rudolf Magnus Institute of Neuroscience, Department of Neurology, University Medical Center, Utrecht, The Netherlands
    Neurology 61:316-21. 2003
    ..The authors investigated the applicability of diagnostic features for diagnosing PM and DM...
  56. ncbi Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralis
    A W R van Kuijk
    Rheumatology (Oxford) 42:1419-20. 2003